Cognigenics
Tracy Brandmeyer is an accomplished professional with extensive expertise in neuroscience and cognitive psychology. Currently serving as Adjunct Faculty at UC San Diego and Chief Technology Officer at Cognigenics, Brandmeyer is instrumental in advancing RNA-based therapeutics for mental disorders. Additional roles include Chief Scientific Officer at BrainMind and Scientific Advisor for several organizations, including Lionheart Ventures and the Institute for Advanced Consciousness Studies. Brandmeyer also founded Āgama Labs, which supports research projects across various stages. Academic credentials include a Ph.D. in Neuroscience from Université Paul Sabatier Toulouse III and a postdoctoral scholarship in Integrative Medicine from the University of California, San Francisco.
This person is not in any teams
This person is not in any offices
Cognigenics
Cognigenics transforms mental health in the genetic age through cognitive neuroengineering. The company’s business is cognitive neuroengineering, which is the genetic engineering of desirable cognitive traits, such as mindfulness, relaxation, and mental acuity. These cognitive assets can enhance human performance in normal individuals or offsetcognitive deficits in people suffering from mental health issues such as stress, anxiety, and depression (which are the initial applications).